Inderpal Singh
General Counsel bei IMMUNIC, INC.
Profil
Inderpal Singh is currently the General Counsel at Immunic, Inc. Prior to this, he worked as the Head of Biopharma at Sandoz International GmbH from 2018 to 2021, Head of Global Manufacturing at Merck KGaA from 2015 to 2017, and Legal Director-Europe Division at Biogen International GmbH from 2013 to 2015.
Singh holds an MBA from both the University of Mannheim and Insead Business School.
Aktive Positionen von Inderpal Singh
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNIC, INC. | General Counsel | 01.06.2021 |
Ehemalige bekannte Positionen von Inderpal Singh
| Unternehmen | Position | Ende |
|---|---|---|
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Corporate Officer/Principal | 01.06.2021 |
| MERCK KGAA | Corporate Officer/Principal | 01.01.2017 |
Biogen International GmbH
 Biogen International GmbH Pharmaceuticals: MajorHealth Technology Biogen International GmbH produces pharmaceuticals. It develops medicines for psoriasis and multiple sclerosis. Its products include FUMADERM and BG-12. The company was founded in 1983 and is headquartered in Lucerne, Switzerland. | Corporate Officer/Principal | 01.01.2015 |
Ausbildung von Inderpal Singh
| University of Mannheim | Masters Business Admin |
| Insead Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MERCK KGAA | Health Technology |
| IMMUNIC, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Health Technology |
Biogen International GmbH
Biogen International GmbH Pharmaceuticals: MajorHealth Technology Biogen International GmbH produces pharmaceuticals. It develops medicines for psoriasis and multiple sclerosis. Its products include FUMADERM and BG-12. The company was founded in 1983 and is headquartered in Lucerne, Switzerland. | Health Technology |
